Smart First Markets: Life Science & Medical Startups

Founders in life science and medical innovation often assume their first path to market must follow the most complex regulatory route. In reality, some of the most effective commercialization strategies begin by identifying adjacent markets with lower barriers to entry, faster customer adoption, and earlier revenue potential.

Join MedStart for a conversation with Dr. Jordan Plews on how life science and medical startups can think more strategically about commercialization. Dr. Plews will explore how innovators can evaluate alternative entry points such as cosmetics, veterinary medicine, wellness, and other adjacent sectors that may offer a more efficient path to market while still building toward larger long-term opportunities.

This session will cover:

• How to think about “first market” strategy for life science startups
• Why some adjacent markets can offer faster commercialization pathways
• How founders can use early market entry to generate traction, validation, and revenue
• What to consider when balancing speed, regulatory complexity, and long-term positioning
• Real-world ways startups can sequence their commercialization strategy more effectively

This event is designed for life science founders, medical innovators, startup executives, and ecosystem partners looking for practical ways to move promising technologies out of the lab and into the market.

If you want something a little punchier for Eventbrite or LinkedIn, here’s a tighter version:

Join MedStart for a practical discussion with Dr. Jordan Plews on faster commercialization strategies for life science and medical startups. Learn how founders can evaluate adjacent markets such as cosmetics and veterinary medicine as strategic first steps to gain traction, generate revenue, and reduce time to market.